Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Agios Pharmaceuticals (AGIO) Tax Provisions (2024)

Historic Tax Provisions for Agios Pharmaceuticals (AGIO) over the last 4 years, with Q4 2024 value amounting to -$8.9 million.

  • Agios Pharmaceuticals' Tax Provisions changed N/A to -$8.9 million in Q4 2024 from the same period last year, while for Sep 2025 it was $44.2 million, marking a year-over-year decrease of 1670.93%. This contributed to the annual value of $44.2 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Agios Pharmaceuticals' Tax Provisions stood at -$8.9 million.
  • Agios Pharmaceuticals' Tax Provisions' 5-year high stood at $53.1 million during Q3 2024, with a 5-year trough of -$8.9 million in Q4 2024.